Advertisement

International Journal of Clinical Pharmacy

, Volume 34, Issue 1, pp 13–16 | Cite as

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

  • Tiene BautersEmail author
  • Barbara Claus
  • Petra Schelstraete
  • Hugo Robays
  • Yves Benoit
  • Catharina Dhooge
Case Report

Abstract

Red man syndrome is a rare but possibly serious adverse reaction during treatment with intravenous vancomycin. It is extremely important that pediatricians, especially in oncology, recognize this reaction and treat it appropriately. Following two case-reports from a pediatric oncology setting, a series of practical recommendations to prevent or handle red man syndrome are described.

Keywords

Clinical pharmacy Pediatric oncology Red man syndrome Vancomycin 

Notes

Funding

None

Conflicts of interest

There are no conflicts of interest.

References

  1. 1.
    Levy M, Koren G, Dupuis L, Read SE. Vancomycin-induced red man syndrome. Pediatrics. 1990;86(4):572–80.PubMedGoogle Scholar
  2. 2.
    Polk RE. Red man syndrome. Ann Pharmacother. 1998;32(7–8):840.PubMedGoogle Scholar
  3. 3.
    Sivagnanam S, Deleu D. Red man syndrome. Crit Care. 2003;7(2):119–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Doherty M. Algorithms for assessing the probability of an adverse drug reaction. Respiratory Medicine CME 2. 2009;63–7.Google Scholar
  5. 5.
    Korman TM, Turnidge JD, Grayson ML. Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother. 1997;39(3):371–81.PubMedGoogle Scholar
  6. 6.
    Levy JH, Marty AT. Vancomycin and adverse drug reactions. Crit Care Med. 1993;21(8):1107–8.PubMedCrossRefGoogle Scholar
  7. 7.
    UpToDate. Inc. Waltham, Massachussets, USA. 2011. http://www.utdol.com. Accessed on July 2011.
  8. 8.
    Vuagnat A, Stern R, Lotthe A, Schuhmacher H, Duong M, Hoffmeyer P, Bernard L. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. J Clin Pharm Ther. 2004;29(4):351–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, et al. The study group. continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob. Agents Chemother. 2001;45(9):2460–7.CrossRefGoogle Scholar
  10. 10.
    Najari Z, Rusho WJ. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. Am J Health-Syst Pharm. 1997;54:181–4.PubMedGoogle Scholar
  11. 11.
    Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2006. URL: http://cp.gsm.com. Updated February 2006.
  12. 12.
    Summary of Product Characteristics Vancocin. 2011. Available from http://www.fagg.be/. Accessed on 13 July 2011.
  13. 13.
    Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis. 1988;157(3):502–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Healy DP, Sahai JV, Fuller SH, Polk RE. Vancomycin-induced histamine release and “red man syndrome”: comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother. 1990;34(4):550–4.PubMedGoogle Scholar
  15. 15.
    Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J. Oral antihistamines reduce the side effects from rapid vancomycin infusion. Anesth Analg. 1998;87(3):681–5.PubMedGoogle Scholar
  16. 16.
    Sahai J, Healy DP, Shelton MJ, Miller JS, Ruberg SJ, Polk R. Comparison of vancomycin- and teicoplanin-induced histamine release and “red man syndrome”. Antimicrob Agents Chemother. 1990;34(5):765–9.PubMedGoogle Scholar
  17. 17.
    Wood MJ. Comparative safety of teicoplanin and vancomycin. J Chemother. 2000;12(S) 5:21–5.Google Scholar
  18. 18.
    Wazny LD, Daghigh B. Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother. 2001;35(11):1458–64.PubMedCrossRefGoogle Scholar
  19. 19.
    Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Tiene Bauters
    • 1
    Email author
  • Barbara Claus
    • 1
  • Petra Schelstraete
    • 2
  • Hugo Robays
    • 1
  • Yves Benoit
    • 3
  • Catharina Dhooge
    • 3
  1. 1.PharmacyGhent University HospitalGhentBelgium
  2. 2.Pediatrics, Infectious DiseasesGhent University HospitalGhentBelgium
  3. 3.Pediatric Hemato-OncologyGhent University HospitalGhentBelgium

Personalised recommendations